The Programme

last update: 28th Mar. 2022
Please note that the programme is subject to change, and will be updated continuously.
All speakers’ lectures will be recorded and available on-demand for a period of 3 months following the actual days of the Conference. Live Broadcast sessions will include live Q&A sections whereby speakers and convenors will be invited to attend the end of their sessions live, to take questions from the participants.
All times are in Central European Time (CEST, UTC+2), Paris, Berlin, Rome, Warsaw. Find the current time for any location or time zone on!

Time in Paris, Berlin, Rome, Warsaw:

Day 1

30 March 2022

7:00-8:00 am CEST

Teaching session
Chairs: Prof. Bo Norrving, Prof. Valery Feigin

07:00 Meet the Immediate Past Editor of European Stroke Journal – Prof. Bo Norrving – Sweden

07:20  Meet the Editor of Neuroepidemiology – Prof. Valery Feigin  – New Zealand

 07:40 Discussion – Q&A

8:00-9:40 am CEST

Plenary session 1: Neurological disorders and COVID-19
Chairs: M.Sc. Erica Westenberg, Prof. Tissa Wijeratne

 08:00 Global COVID-19 Neuro Research Coalition – M.Sc. Erica Westenberg – Germany

 08:10 Telemedicine in Neurology since the COVID-19 pandemic – Prof. Maurice Giroud – France

 08:22 Neurological rehabilitation during the COVID-19 pandemic: What changes and what have we learnt – Prof. Dorcas Gandhi – India

 08:50 Post Covid-19 Neurological Syndrome – status and future perspective – Prof. Tissa Wijeratne – Australia

 09:05 Telerehabilitation for Neurological care- how real is the impact across the world- HIC versus LMIC perspectives – Prof. Dorcas       Gandhi – India

09:34 Primary stroke and cardiovascular disease prevention strategy needs overhaul – Prof. Valery Feigin – New Zealand

09:44 Discussion – Q&A

09:55-10:35 am CEST

Break – Poster Viewing and Oral Presentation (Video on Demand section)

10:35-10:50 am CEST

Plenary session 2: Application of risk prediction (scores) in neurology
Chairs: Prof. Derrick Bennett, PhD Matthew Chun

10:35 Stroke risk prediction using machine learning: a prospective cohort study of 0.5 million Chinese adults – PhD Matthew Chun – UK

10:50-12:00 pm CEST

Plenary session III: Neuroepidemiology of cognition
Chairs: Prof. Anna K. Bonkhoff, Dr. Dearbhla Kelly

10:50 Lesion location helps to better understand cognitive impact of cerebrovascular disease: the Mata VCI Map consortium – Prof. Geert Jan Biessels – Netherlands

11:05 Targeting exercise to prevent vascular cognitive impairment: the Post-Ischaemic Stroke Cardiovascular Exercise Study – Prof. Amy Brodtmann – Australia

11:16 Epidemiology and novel risk factors for dementia after stroke – Prof. Sarah Pendlebury – UK

11:31 Preventing Vascular Cognitive Impairment with multiple lifestyle interventions – Prof. Christopher Chen – Singapore

11:46 Discussion – Q&A

12:00-12:30 pm CEST

Plenary session IV: Genetics and Application of Mendelian Randomisation in neurology
Chairs: Dr. Eric Harshfield, Prof. Suzanna Larsson

12:00 Metabolic associations with ischaemic stroke, dementia, and imaging markers of cerebral small vessel disease: a comprehensive metabolomics study – Dr. Eric Harshfield – UK

12:09 Genetics of stroke in Africans – PhD Rufus Akinyemi – Nigeria

12:26 Discussion – Q&A

12:30-13:20 pm CEST

Break – Poster Viewing and Oral Presentation (Video on Demand section)

13:20-15:15 pm CEST

Plenary session 5: Epidemiology of multiple sclerosis, ALD and demyelinating diseases
Chairs: Prof. Carlos N. Ketzoian, Prof. Fernando Gracia

13:20 Multiple Sclerosis Incidence in Uruguay: A Population-based Study- Prof. Carlos N. Ketzoian – Uruguay

13:36 Barriers to access and utilization of multiple sclerosis care services in Latin American patients – MD Jorge Correale – Argentina

13:57 Poverty and neurological disorders in middle-low income countries – Prof. Carlos N. Ketzoian – Uruguay

14:13 Prevalence and incidence surveys of MS in Latin America and the Caribbean – Prof. Fernando Gracia – Panama

14:31 Environmental factors involved in the development of MS in Latin America – MD Jorge Correale – Argentina

14:59 Discussion – Q&A

15:15-18:06 pm CEST

Special session: Brain Health, One Health and COVID-19
Chairs: Prof. David Wiebers, Prof. Andrea Winkler

15:15 Brain Health, One Health, COVID-19 and Our Collective Future – Prof. David Wiebers – USA

15:34 ‘Brain Health’: vision or study endpoint? – Prof. Michael Brainin – Austria

15:59 Advantages of a One Health Approach For Communicable and Noncommunicable Diseases – Prof. Andrea Winkler – Germany

16:28 One Welfare, the Role of Health Professionals and Climate Change – Dr Anne Quain – Australia

16:49 Harm, Earth Juris Prudence and Human/Nonhuman Relationships – Prof.Tanya Wyatt – UK

17:09 Rethinking Global Governance to Address Zoonotic Disease Risk – Prof. Kelley Lee – Canada

17:36 Discussion – Q&A

Day 2

31 March 2022

7:00-8:30 am CEST

Plenary Session 6: Statistical techniques to improve the use of observational data
Chairs: Prof. Dominique Cadilhac, Christian Gunge Riberholt

07:00 Propensity score techniques – Dr. Muideen Olaiya – Australia

07:15 Statistical considerations for reducing the risk of type I or II errors in systematic reviews and meta-analysis – Christian Gunge Riberholt – Denmark

07:29 Target trial approach in comparative effectiveness studies
for stroke – A/Prof. Monique Kilkenny – Australia

07:44 Patient reported outcomes for guiding clinical practice, comparing service performance, and clinical data interpretation – Prof. Dominique Cadilhac – Australia

07:59 Discussion – Q&A

8:30-11:45 am CEST

Plenary session 7: Innovations in epidemiology of neurological disorders in LMIC
Chairs: Prof. Jeyaraj Pandian, Prof. Wenzhi Wang

8:30 Artificial Intelligence in stroke epidemiology – Prof. Jeyaraj Pandian – India

08:45 Epidemiology and community control of epilepsy in rural areas of China – Prof. Wenzhi Wang – China

09:00 Neuropsychological rehabilitation in low resource settings – Challenges and outcomes – Prof. Jagjit S. Chopra – Singapore

09:12 Methodology for documentation of stroke deaths in LMICs: challenges and way forward – Prof. Jeyaraj Pandian – India

09:24 Epidemiology of brain injury – Prof. Dongling Sun – China

09:36 How to integrate stroke implementation research in health care system of developing countries – Prof. Jeyaraj Pandian – India

09:49 Epidemiology of stroke and TIA. – Prof. Siqi Ge – China

10:04 Cognitive and psychological rehabilitation in psychogenic non-epileptic seizures versus generalized epilepsy – Prof. Jagjit S. Chopra – Singapore

10:16 Challenges and Opportunities of neurological research insub-Saharan Africa – Prof. Andrea Winkler – Germany

10:29 Discussion – Q&A

10:30-11:45 am CEST

Break – Poster Viewing and Oral Presentation (Video on Demand section)

11:45-14:15 pm CEST

Scientific session 1: Stroke and dementia
Chairs: Dr Margit Alt Murphy, MD Denis Gabriel

11:45 Upper limb sensorimotor assessment after stroke – recommendations and implementation – Dr Margit Alt Murphy – Sweden

12:04 Cognition, function and prevalent dementia in Centenarians and Near-Centenarians: an individual participant data (IPD) meta-analysis of 18 studies – Prof. Perminder Sachdev – Australia

12:20 MTHFR and risk of stroke, ischemic heart disease and major non-vascular diseases: a Mendelian randomization study of Chinese adults – Prof. Derrick Bennett – UK

12:43 Virtual Reality in stroke rehabilitation – Dr Margit Alt Murphy– Sweden

13:03 Causal associations of blood lipids with risk of ischaemic stroke and intracerebral haemorrhage – Prof. Derrick Bennett – UK

13:24 The burden of stroke in Africa – PhD Rufus Akinyemi – Nigeria

13:42 Long-term prognosis of primary intracerebral haemorrhage in XXI century hospital cohorts compared to populations-based cohorts – MD Denis Gabriel – Portugal

13:53 Discussion – Q&A

14:15-15:30 pm CEST

Scientific session 2: Using research to change stroke policies
Chairs: Prof. Sheila Martins, Prof. Yannick Béjot

14:15 How to use registries and epidemiological data to change policies? – Prof. Sheila Martins – Brazil

14:32 Clinical profile gap between stroke patients included in therapeutic trials and those in real-life practice: an important issue to deal with – Prof. Yannick Béjot – France

14:46 How to translate clinical trials in national policies?- Prof. Octavio Marques Pontes Neto – Brazil

15:01 The gaps and solutions for primary prevention across the globe – to show the gaps and what the countries are doing to improve – Prof. Sheila Martins – Brazil

15:15 Discussion – Q&A

15:30-16:40 pm CEST

Scientific session 3: International networks to advance neurological science & practice
Chairs: Prof. Marian Brady, Prof. Julie Bernhardt

15:30 The Power of Dance for Parkinson’s: Developing Global Networks – Prof. Meg Morris – Australia

15:47 The Collaboration of Aphasia Trialists; standardizing assessments to measure aphasia rehabilitation – Prof. Carolina Mendez Orellana – Chile

15:57 Global Collaboration: Lessons from Multiple Sclerosis – Prof. Robert J Fox – USA

16:08 The International Stroke Recovery & Rehabilitation Alliance – Prof. Geert Verhyeden – Belgium

16:21 Discussion – Q&A

Day 3

1 April 2022

9:00-11:10 am CEST

Plenary session 8: Cognitive impairment and dementia
Chairs: Prof. Yannick Béjot, Prof. Giancarlo Logroscino

09:00 Stroke in patients with cognitive impairment – Prof. Yannick Béjot – France

09:16 Epidemiology, profile and determinant of post – stroke vascular cognitive impairment – PhD Rufus Akinyemi – Nigeria

09:35 Diagnosis and management of post-stroke cognitive impairment in clinical practice – Prof. Olivier Godefroy – France

09:52 Frontiers: FTD Incidence in Europe – Prof. Giancarlo Logroscino – Italy

10:03 Cerebral small vessel disease in patients with cognitive decline – Prof. Stéphanie Debette – France

10:21 Cognitive Impairment and Hearing Loss – Prof. Giancarlo Logroscino – Italy

10:38 Olfactory dysfunction and cognitive decline among older adults – Prof. Ding Ding – China

10:58 Discussion – Q&A

11:15-13:30 pm CEST

Plenary session 9: epidemiology of neurodegenerative disorders, epilepsy and headaches
Chairs:  Prof. Tissa Wijeratne

11:15 Epidemiology of headache disorders in Emergency Department; Global perspectives and unmet need – Prof. Tissa Wijeratne – Australia

11:29 Sudden onset death in epilepsy (SUDEP): Can it be prevented? – Prof. Terence O’Brien – Australia

11:46 Psychotic and Behavioral Symptoms in neurodegenerative diseases – Prof. Giancarlo Logroscino – Italy

12:01 Epidemiology of epilepsy in South East Asian Region – Prof. Jithangi Wanigasinghe – Sri Lanka

12:16 100 million people – the success story of World Brain Day, reflections on global advocacy in neurology – Prof. Tissa Wijeratne – Australia

12:33 Antecedent autoimmune conditions and amyotrophic lateral sclerosis – Dr Jessica Hinman – USA

12:46 New perspectives in research for Alzheimer Disease – Prof. Eduardo Zimmer – Brazil

13:01 Diabetes, Diabetes Medicationsand the Risk of Developing ALS – Prof. Lorene Nelson – USA

13:11 Discussion – Q&A

13:26-13:30 pm CEST

Closing remarks, awards

Endorsed by